Synonyms:
Status: Phase 1
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: 2CQ62IWB67

Structure

InChI Key NIDRNVHMMDAAIK-YPMLDQLKSA-N
Smile NC1=N[C@@]2(c3cc(NC(=O)c4ccc(F)cn4)ccc3F)COC[C@H]2CS1
InChI
InChI=1S/C18H16F2N4O2S/c19-11-1-4-15(22-6-11)16(25)23-12-2-3-14(20)13(5-12)18-9-26-7-10(18)8-27-17(21)24-18/h1-6,10H,7-9H2,(H2,21,24)(H,23,25)/t10-,18-/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C18H16F2N4O2S
Molecular Weight 390.42
AlogP 2.52
Hydrogen Bond Acceptor 6.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 3.0
Polar Surface Area 89.6
Molecular species NEUTRAL
Aromatic Rings 2.0
Heavy Atoms 27.0

Pharmacology

Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Enzyme Protease Aspartic protease Aspartic protease AA clan Aspartic protease A1A subfamily
- 12-20 - - -

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Alzheimer Disease 1 D000544 ClinicalTrials

Related Entries

Scaffolds

Cross References

Resources Reference
ChEMBL CHEMBL2396989
DrugBank DB12547
EPA CompTox DTXSID70155117
FDA SRS 2CQ62IWB67
Guide to Pharmacology 6475
PDB 3YS
PubChem 49837968
SureChEMBL SCHEMBL966802
ZINC ZINC000070466423